tiprankstipranks
Blogger Profile
Followed by 4 other investors
.
bricklebar

bricklebar

Hot Copper
Financial Blogger
Ranked #5,125 out of 13,589 Bloggers on TipRanks (#9,346 out of 21,629 overall experts)

Success Rate

40%
2 out of 5 Profitable Transactions

Average Return

9.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied bricklebar's ratings since 2022 and opened each position for the duration of 1 Year:
40.00% of your transactions would have been profitable with an average return of 9.0%

Stock Rating Distribution

23Ratings
100.00% Buy
0.00% Hold
0.00% Sell
Distribution of bricklebar's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market
GermanyGermany Market
AustraliaAustralian Market

Best Rating

Stock:
Clinuvel Pharmaceuticals Limited
(CLVLF)
Rating Type:Buy
Dates:Jun 17, 2022 - Jan 01, 1970
Gain:37.50%
The most profitable rating made by bricklebar

bricklebar's Stock Coverage

Company Name
Date
Position
Success Rate
Avg Return
No. of Ratings
Greenland Minerals Limited
Apr 12, 2022
Buy
0.00%
1
Tesserent Ltd.
Apr 23, 2022
Buy
0.00%
1
Metals Australia Ltd
Apr 27, 2022
Buy
0.00%
1
EnviroSuite Ltd
May 23, 2022
Buy
0.00%
1
Living Cell Technologies Ltd.
Jun 08, 2022
Buy
0.00%
1
Adairs Ltd.
Jun 17, 2022
Buy
0.00%
1
Southern Cross Media Group Limited
Jun 17, 2022
Buy
0.00%
2
Clinuvel Pharmaceuticals Limited
Jun 17, 2022
Buy
100%
+37.50%
1
Harvey Norman Holdings Ltd
Jun 22, 2022
Buy
0%
0.00%
2
Elmore Limited
Jul 01, 2022
Buy
0.00%
5
List of latest recommendations made by bricklebar. Click to expand and see bricklebar's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.